arrow
M

Marek Kovář

institute of microbiology of the czech academy of sciences
H指数:30
被引数:3,524

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gemcitabine release kinetics determines the anticancer and immunomodulatory activity of HPMA copolymer nanomedicines

聚乙二醇-羟乙基甲基丙烯酰胺共聚物纳米药物中吉西他滨释放动力学决定其抗癌和免疫调节活性

2026-09-230
OAAI
NKG2A inhibition promotes NK cell-CD8+ T cell interactions to improve anticancer immunity in ovarian carcinoma

NKG2A抑制促进NK细胞-CD8+ T细胞相互作用以改善卵巢癌的抗肿瘤免疫

2026-04-170
OAAI
Overcoming P-glycoprotein-mediated multidrug resistance in cancer cells through micelle-forming PHPMA-b-PPO diblock copolymers for doxorubicin delivery (vol 381, 113645, 2025)

通过形成胶束的PHPMA-b-PPO嵌段共聚物克服癌细胞中P-糖蛋白介导的多药耐药性用于多柔比星递送(卷381,113645,2025)

2025-06-010
PRE
High-throughput phenotyping of buckwheat (Fagopyrum esculentum Moench.) genotypes under water stress: exploring drought resistance for sustainable agriculture (vol 25, 444, 2025)

荞麦(Fagopyrum esculentum Moench.)基因型在水分胁迫下的高通量表型分析:探索抗旱性以实现可持续农业(卷 25,444,2025)

2025-04-240
OA
Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activity
2024-09-241
OA
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer

三级淋巴结构和b细胞决定卵巢癌的临床相关T细胞表型

2024-03-2113
OAAI
Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling
2021-04-0110
PREAI